BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16364177)

  • 1. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
    Caldas A; Favali C; Aquino D; Vinhas V; van Weyenbergh J; Brodskyn C; Costa J; Barral-Netto M; Barral A
    BMC Infect Dis; 2005 Dec; 5():113. PubMed ID: 16364177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis.
    de Medeiros IM; Castelo A; Salomão R
    Rev Inst Med Trop Sao Paulo; 1998; 40(1):31-4. PubMed ID: 9713135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.
    Gatto M; de Abreu MM; Tasca KI; de Assis Golim M; da Silva LD; Simão JC; Fortaleza CM; de Campos Soares ÂM; Calvi SA
    PLoS One; 2015; 10(2):e0117977. PubMed ID: 25706930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia.
    Tadesse D; Abdissa A; Mekonnen M; Belay T; Hailu A
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009632. PubMed ID: 34351903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection.
    Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Van Weyenbergh J; Correa-Oliveira R
    Clin Exp Immunol; 2006 Oct; 146(1):124-32. PubMed ID: 16968407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.
    Carvalho LP; Passos S; Dutra WO; Soto M; Alonso C; Gollob KJ; Carvalho EM; Ribeiro de Jesus A
    Scand J Immunol; 2005 Apr; 61(4):337-42. PubMed ID: 15853916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis.
    Bacellar O; D'oliveira A; Jerônimo S; Carvalho EM
    Cytokine; 2000 Aug; 12(8):1228-31. PubMed ID: 10930301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe visceral leishmaniasis in children: the relationship between cytokine patterns and clinical features.
    Gama ME; Gomes CM; Silveira FT; Laurenti MD; Gonçalves Eda G; Silva AR; Corbett CE
    Rev Soc Bras Med Trop; 2013; 46(6):741-5. PubMed ID: 24474016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
    J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
    Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
    J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome.
    Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Correa-Oliveira R
    Scand J Immunol; 2005 Nov; 62(5):487-95. PubMed ID: 16305646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis.
    Disch J; Oliveira MC; Orsini M; Rabello A
    Acta Trop; 2004; 92(3):279-83. PubMed ID: 15533299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of American visceral leishmaniasis.
    Lemos EM; Gomes IT; Carvalho SF; Rocha RD; Pissinate JF; Martins-Filho OA; Dietze R
    Clin Vaccine Immunol; 2007 May; 14(5):569-76. PubMed ID: 17360851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J; Karmakar S; De T
    Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated TGF-beta levels in drug-resistant visceral leishmaniasis.
    Elmekki MA; Elhassan MM; Ozbak HA; Mukhtar MM
    Ann Saudi Med; 2016; 36(1):73-7. PubMed ID: 26922691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.